Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Privacy Policy  
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Successful stem-cell transplantation in a dog with cancer
It has become a routine procedure in human medicine over years now: Stem-cells are transplantated and allow patients with cancer to be cured or at least to benefit from this kind of therapy. Now the first dog with T-cell lymphoma, a golden Retriever, has been treated with a stem-cell transplant. A mile-stone in canine oncology!

`This is the right time for veterinary medicine to take a big step,` says Dr. Edmund Sullivan, Bellingham Veterinary and Critical Care, Bellingham, Wash. `There is definitely a market for the procedure and dogs have better lives, longer.`

Few dogs have received stem-cell transplants, largely due to the price tag that accompanies the procedure — approximately $45,000. But over time, some of the cost can be eliminated.

One DVM says general practitioners are not fully aware of how the procedure is performed and could offer the treatment to clients.

`General practitioners do not typically perform such a procedure,` Sullivan says. `It`s a big job to organize the procedure, but it isn`t a difficult job. We don`t want Comet (the transplant recipient) to be an isolated event.`

Sullivan matched blood types with the Golden Retriever and performed the transplant with help from the Fred Hutchinson Cancer Research Center (FHCRC). Sullivan is a general practitioner with special interest in transplant biology.

It the latest case, the Golden Retriever`s spleen was removed, and total body radiation treatment was given to kill cancerous cells.

The FHCRC separated stem-cells from the donor dog`s blood then intravenously administered the healthy cells to the transplant recipient, beginning new healthy cell growth. The dog then was restricted to isolation for 14 days while immune cells grew.

`We want to set up a protocol for the stem-cell transplant,` Sullivan says. `It would really benefit veterinarians, clients and of course pets if a blueprint can be formulated. General practitioners could then give their clients the option of having a stem-cell transplant performed on their pet.`

The dog developed sores on its muzzle when the stem-cells rejected the new environment. However, cyclosporine was used to remedy the problem, Sullivan says. At this time, the dog is cancer-free one year after the transplant.

`It took a while to regulate the amount of medication needed to keep the dog healthy,` he adds. `But now he runs five miles a day with his owner. This is a dog that was dying of cancer a year ago.`


`For us, this is pretty fantastic,` Sullivan says. `I`ve seen so many dogs with lymphoma and they`ve all died.`





Source: www.dvmnewsmagazine.com/dvm/


Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Toceranib phosphate (Palladia®) in canine gastrointestinal stromal tumorsmembers
Gastrointestinal stromal tumors (GISTs) are uncommon intestinal neoplasms in the dog. Literature regarding adjunctive therapy for GISTs in dogs is sparse. High‐risk GISTs in humans respond to tyrosine kinase inhibition in the adjuvant setting. This recently online published study reviews cases of toceranib phosphate use in dogs with GISTs and provides initial assessment of possible biological activity. A secondary aim was to evaluate patient and tumor characteristics for possible prognostic value.

  • Radioactive iodine uptake in hyperthyroid cats after rh-TSHmembers
  • Punica granatum associated with hepatotoxicosis in cattle
  • Hypoechoic tissue changes in dogs with malignant prostatic lymphomamembers
  • Emphysematous gastritis in dogs and catsmembers
  • Primary pulmonary histiocytic sarcoma in dogsmembers
  • Determining prognosis in canine sepsis members
  • Correlation of plasma and tear glucose, creatinine and urea nitrogen in catsmembers
  • Perineal hernias in dogs - always a bilateral problem?members
  • Pharmacokinetic of gabapentin in catsmembers
  • Follicular development of canine ovaries stimulated by eCG plus hCGmembers
  • Gastrointestinal effects following acupuncture in healthy dogsmembers
  • Bilateral repair of apparently unilateral perineal hernias in dogsmembers


  • [ Home ] [ About ] [ Contact / Request ] [ Privacy Policy ]

    Copyright © 2001-2018 VetContact GmbH
    All rights reserved